Reuters logo
BRIEF-AstraZeneca, Lilly receive FDA fast track designation for AZD3293
August 22, 2016 / 10:56 AM / a year ago

BRIEF-AstraZeneca, Lilly receive FDA fast track designation for AZD3293

Aug 22 (Reuters) - AstraZeneca Plc :

* AstraZeneca and Lilly receive FDA fast track designation for AZD3293, an investigational treatment for early Alzheimer‘S disease Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below